BMI对幼儿胰岛自身免疫风险的影响依赖于HLA-DR4-DQ8且无HLA-DR3-DQ2
该研究基于TEDDY队列中7,724名胰岛自身免疫(IA)高风险儿童,采用纵向BMI与IA事件的联合模型分析。结果显示婴儿期BMI z评分与18个月前IA风险无关,但1.5至8.5岁及8.5至15岁期间BMI与IA风险升高相关。9个月龄后高BMI z评分(SD>0.5)在早期儿童期增加IA风险,且该效应仅见于HLA-DR4/4或HLA-DR4/8基因型儿童,未见与HLA-DR3/3或HLA-DR3/4的交互作用。
要点
- 婴儿期BMI z评分与18个月前IA风险无关(HR 1.03)。
- 1.5至8.5岁及8.5至15岁BMI与IA风险升高相关(HR 1.20和1.27)。
- 9个月龄后高BMI增加早期儿童期IA风险,仅见于HLA-DR4/4或HLA-DR4/8儿童。
核心结论
- 早期儿童期BMI对IA风险的贡献更多依赖于HLA-DR-DQ基因型而非首先出现的IA表型。
研究设计与样本
- 研究纳入TEDDY研究中7,724名IA高风险儿童,至少有三个BMI测量值。
- 采用纵向BMI与时间至IA事件的联合模型,分析婴儿期(2周至1.5岁,n=7,724)、早期儿童期(1.5-8.5岁,n=6,396)和青春期(8.5-15岁,n=4,732)的BMI z评分及变化。
主要发现
- 婴儿期BMI z评分与18个月前IA风险无关(n=185,HR 1.03 [95% CI 0.88, 1.19])。
- 1.5至8.5岁期间BMI与IA风险升高相关(n=470,HR 1.20 [95% CI 1.04, 1.32])。
- 8.5至15岁期间BMI与IA风险升高相关(n=209,HR 1.27 [95% CI 1.09, 1.49])。
- 未观察到与首先出现的IA表型的交互作用。
- 9个月龄后高BMI z评分(SD>0.5)增加早期儿童期IA风险,仅见于HLA-DR4/4或HLA-DR4/8儿童,未见HLA-DR3/3或HLA-DR3/4(HLA×BMI交互作用,P<0.005)。
临床怎么用
- 对于携带HLA-DR4/4或HLA-DR4/8基因型的高风险儿童,关注9个月龄后BMI z评分升高可能有助于评估早期儿童期IA风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Childhood obesity may impact the risk of islet autoimmunity (IA). The trajectory of BMI through childhood resembles the early peak incidence of first-appearing autoantibodies against insulin (IAA-first) but not GAD65 (GADA-first). We studied whether a child's BMI can impact the age-related risk of first-appearing IA phenotypes. RESEARCH DESIGN AND METHODS: We identified 7,724 children at risk for IA with at least three BMI measurements in The Environmental Determinants of Diabetes in the Young (TEDDY) study. We modeled the risk of IAA-first, GADA-first, and IA overall on a child's BMI z score and change in BMI during infancy (age 2 weeks to 1.5 years, n = 7,724), early childhood (age 1.5-8.5 years, n = 6,396), and puberty (age 8.5-15 years, n = 4,732) using joint modeling of longitudinal BMI and time-to-event IA. RESULTS: An infant's BMI z score was not associated with IA risk before 18 months of age (n = 185, hazard ratio [HR] 1.03 [95% CI 0.88, 1.19]). In contrast, a child's BMI correlated with an increased risk of IA from 1.5 to 8.5 years of age (n = 470, HR 1.20 [95% CI 1.04, 1.32]) and from 8.5 to 15 years of age (n = 209, HR 1.27 [95% CI 1.09, 1.49]). No interactions with first-appearing IA phenotypes were observed. However, high BMI z score (SD >0.5) from age 9 months increased the risk of IA in early childhood, specifically for children with HLA-DR4/4 or HLA-DR4/8 and not with HLA-DR3/3 or HLA-DR3/4 (HLA ∗ BMI interaction, P < 0.005). CONCLUSIONS: The contribution of BMI to risk of IA during early childhood is dependent on the HLA-DR-DQ genotype more so than the first-appearing IA phenotype.
引用
- Koskenniemi JJ, Clasen JL, You L, et al. The Contribution of BMI to a Young Child's Risk of Islet Autoimmunity Is Dependent on HLA-DR4-DQ8 Without HLA-DR3-DQ2. Diabetes Care. 2025. PMID: 41066490. doi:10.2337/dc25-1198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。